Shilpa Medicare partners with Orion for Recombinant Human Albumin for European market
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
The CDMO upgrade represents a transformational step for Remedium Lifecare
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
This outcome reflects Innoxel Lifesciences' ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
Subscribe To Our Newsletter & Stay Updated